Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Peptide-based Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Sanofi
The Medicines
Takeda
Ferring
J & J
Eli Lilly
Novartis
AstraZeneca
Teva
Merck
AbbVie
By Type:
Oral
Other
Injection
By Application:
Central Nervous System
Other
Metabolic Disorders
Cancer
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Peptide-based Drug Market Overview 2018-2029
-
1.1 China Peptide-based Drug Industry Development Overview
-
1.2 China Peptide-based Drug Industry Development History
-
1.3 China Peptide-based Drug Industry Market Size (2018-2029)
-
1.4 China Peptide-based Drug Market Analysis by Type from Production Side
-
1.4.1 China Peptide-based Drug Production Volume, Production Value and Growth Rate of Oral (2018-2029)
-
1.4.2 China Peptide-based Drug Production Volume, Production Value and Growth Rate of Other (2018-2029)
-
1.4.3 China Peptide-based Drug Production Volume, Production Value and Growth Rate of Injection (2018-2029)
-
1.5 China Peptide-based Drug Market Analysis by Application from Consumption End
-
1.5.1 China Peptide-based Drug Sales Volume, Sales Value and Growth Rate of Central Nervous System (2018-2029)
-
1.5.2 China Peptide-based Drug Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
1.5.3 China Peptide-based Drug Sales Volume, Sales Value and Growth Rate of Metabolic Disorders (2018-2029)
-
1.5.4 China Peptide-based Drug Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)
-
1.6 China Peptide-based Drug Market Analysis by Region
-
1.6.1 North China Peptide-based Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Peptide-based Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Peptide-based Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Peptide-based Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Peptide-based Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Peptide-based Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Peptide-based Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Peptide-based Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Peptide-based Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Peptide-based Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Peptide-based Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Peptide-based Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Peptide-based Drug Industry Development
Chapter 3 Peptide-based DrugIndustry Chain Analysis
-
3.1 Peptide-based Drug Industry Chain
-
3.2 Peptide-based Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Peptide-based Drug Market
-
3.3 Peptide-based Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Peptide-based Drug Market
Chapter 4 China Peptide-based Drug Market, by Type
-
4.1 China Peptide-based Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Peptide-based Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Peptide-based Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Peptide-based Drug Production Volume and Growth Rate of Oral
-
4.5.2 China Peptide-based Drug Production Volume and Growth Rate of Other
-
4.5.3 China Peptide-based Drug Production Volume and Growth Rate of Injection
Chapter 5 China Peptide-based Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Peptide-based Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Peptide-based Drug Market Size and Growth Rate, by Application
-
5.5.1 China Peptide-based Drug Market Size and Growth Rate of Central Nervous System
-
5.5.2 China Peptide-based Drug Market Size and Growth Rate of Other
-
5.5.3 China Peptide-based Drug Market Size and Growth Rate of Metabolic Disorders
-
5.5.4 China Peptide-based Drug Market Size and Growth Rate of Cancer
Chapter 6 China Peptide-based Drug Market, by Region
-
6.1 China Peptide-based Drug Production Volume and Production Value, by Region
-
6.2 China Peptide-based Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Peptide-based Drug Market Analysis
-
7.1 North China Peptide-based Drug Market, by Type
-
7.2 North China Peptide-based Drug Market, by Application
Chapter 8 Central China Peptide-based Drug Market Analysis
-
8.1 Central China Peptide-based Drug Market, by Type
-
8.2 Central China Peptide-based Drug Market, by Application
Chapter 9 South China Peptide-based Drug Market Analysis
-
9.1 South China Peptide-based Drug Market, by Type
-
9.2 South China Peptide-based Drug Market, by Application
Chapter 10 East China Peptide-based Drug Market Analysis
-
10.1 East China Peptide-based Drug Market, by Type
-
10.2 East China Peptide-based Drug Market, by Application
Chapter 11 Northeast China Peptide-based Drug Market Analysis
-
11.1 Northeast China Peptide-based Drug Market, by Type
-
11.2 Northeast China Peptide-based Drug Market, by Application
Chapter 12 Southwest China Peptide-based Drug Market Analysis
-
12.1 Southwest China Peptide-based Drug Market, by Type
-
12.2 Southwest China Peptide-based Drug Market, by Application
Chapter 13 Northwest China Peptide-based Drug Market Analysis
-
13.1 Northwest China Peptide-based Drug Market, by Type
-
13.2 Northwest China Peptide-based Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 Sanofi
-
14.1.1 Sanofi Company Profile
-
14.1.2 Sanofi Peptide-based Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 The Medicines
-
14.2.1 The Medicines Company Profile
-
14.2.2 The Medicines Peptide-based Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Takeda
-
14.3.1 Takeda Company Profile
-
14.3.2 Takeda Peptide-based Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Ferring
-
14.4.1 Ferring Company Profile
-
14.4.2 Ferring Peptide-based Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 J & J
-
14.5.1 J & J Company Profile
-
14.5.2 J & J Peptide-based Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Eli Lilly
-
14.6.1 Eli Lilly Company Profile
-
14.6.2 Eli Lilly Peptide-based Drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Novartis
-
14.7.1 Novartis Company Profile
-
14.7.2 Novartis Peptide-based Drug Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 AstraZeneca
-
14.8.1 AstraZeneca Company Profile
-
14.8.2 AstraZeneca Peptide-based Drug Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Teva
-
14.9.1 Teva Company Profile
-
14.9.2 Teva Peptide-based Drug Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Merck
-
14.10.1 Merck Company Profile
-
14.10.2 Merck Peptide-based Drug Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 AbbVie
-
14.11.1 AbbVie Company Profile
-
14.11.2 AbbVie Peptide-based Drug Market Performance
-
14.11.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Peptide-based Drug Industry Research Conclusions
-
15.2 Peptide-based Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Peptide-based Drug Industry Market Size (2018-2029)
-
Figure China Peptide-based Drug Production Volume, Production Value and Growth Rate of Oral (2018-2029)
-
Figure China Peptide-based Drug Production Volume, Production Value and Growth Rate of Other (2018-2029)
-
Figure China Peptide-based Drug Production Volume, Production Value and Growth Rate of Injection (2018-2029)
-
Figure China Peptide-based Drug Sales Volume, Sales Value and Growth Rate of Central Nervous System (2018-2029)
-
Figure China Peptide-based Drug Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
Figure China Peptide-based Drug Sales Volume, Sales Value and Growth Rate of Metabolic Disorders (2018-2029)
-
Figure China Peptide-based Drug Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)
-
Figure North China Peptide-based Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Peptide-based Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Peptide-based Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Peptide-based Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Peptide-based Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Peptide-based Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Peptide-based Drug Market Size and Growth Rate from 2018-2029
-
Figure Peptide-based Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Peptide-based Drug Market Share by Type in 2018
-
Figure China Peptide-based Drug Market Share by Type in 2023
-
Figure China Peptide-based Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Peptide-based Drug Production Volume and Growth Rate of Oral (2018-2023)
-
Figure China Peptide-based Drug Production Volume and Growth Rate of Other (2018-2023)
-
Figure China Peptide-based Drug Production Volume and Growth Rate of Injection (2018-2023)
-
Figure China Peptide-based Drug Market Share by Application in 2018
-
Figure China Peptide-based Drug Market Share by Application in 2023
-
Figure China Peptide-based Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Peptide-based Drug Market Size and Growth Rate of Central Nervous System (2018-2023)
-
Figure China Peptide-based Drug Market Size and Growth Rate of Other (2018-2023)
-
Figure China Peptide-based Drug Market Size and Growth Rate of Metabolic Disorders (2018-2023)
-
Figure China Peptide-based Drug Market Size and Growth Rate of Cancer (2018-2023)
-
Table China Peptide-based Drug Production Volume by Region (2018-2023)
-
Table China Peptide-based Drug Production Volume Share by Region (2018-2023)
-
Figure China Peptide-based Drug Production Volume Share by Region (2018-2023)
-
Table China Peptide-based Drug Production Value by Region (2018-2023)
-
Table China Peptide-based Drug Production Value Share by Region (2018-2023)
-
Figure China Peptide-based Drug Production Value Share by Region (2018-2023)
-
Table China Peptide-based Drug Sales Volume by Region (2018-2023)
-
Table China Peptide-based Drug Sales Volume Share by Region (2018-2023)
-
Figure China Peptide-based Drug Sales Volume Share by Region (2018-2023)
-
Table China Peptide-based Drug Sales Value by Region (2018-2023)
-
Table China Peptide-based Drug Sales Value Share by Region (2018-2023)
-
Figure China Peptide-based Drug Sales Value Share by Region (2018-2023)
-
Table North China Peptide-based Drug Production Volume by Type (2018-2023)
-
Table North China Peptide-based Drug Production Volume Share by Type (2018-2023)
-
Figure North China Peptide-based Drug Production Volume Share by Type (2018-2023)
-
Table North China Peptide-based Drug Sales Volume by Application (2018-2023)
-
Table North China Peptide-based Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Peptide-based Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Peptide-based Drug Production Volume by Type (2018-2023)
-
Table Central China Peptide-based Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Peptide-based Drug Production Volume Share by Type (2018-2023)
-
Table Central China Peptide-based Drug Sales Volume by Application (2018-2023)
-
Table Central China Peptide-based Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Peptide-based Drug Sales Volume Share by Application (2018-2023)
-
Table South China Peptide-based Drug Production Volume by Type (2018-2023)
-
Table South China Peptide-based Drug Production Volume Share by Type (2018-2023)
-
Figure South China Peptide-based Drug Production Volume Share by Type (2018-2023)
-
Table South China Peptide-based Drug Sales Volume by Application (2018-2023)
-
Table South China Peptide-based Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Peptide-based Drug Sales Volume Share by Application (2018-2023)
-
Table East China Peptide-based Drug Production Volume by Type (2018-2023)
-
Table East China Peptide-based Drug Production Volume Share by Type (2018-2023)
-
Figure East China Peptide-based Drug Production Volume Share by Type (2018-2023)
-
Table East China Peptide-based Drug Sales Volume by Application (2018-2023)
-
Table East China Peptide-based Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Peptide-based Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Peptide-based Drug Production Volume by Type (2018-2023)
-
Table Northeast China Peptide-based Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Peptide-based Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Peptide-based Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Peptide-based Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Peptide-based Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Peptide-based Drug Production Volume by Type (2018-2023)
-
Table Southwest China Peptide-based Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Peptide-based Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Peptide-based Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Peptide-based Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Peptide-based Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Peptide-based Drug Production Volume by Type (2018-2023)
-
Table Northwest China Peptide-based Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Peptide-based Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Peptide-based Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Peptide-based Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Peptide-based Drug Sales Volume Share by Application (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Peptide-based Drug Revenue, Price and Gross (2018-2023)
-
Table The Medicines Company Profile
-
Table The Medicines Peptide-based Drug Revenue, Price and Gross (2018-2023)
-
Table Takeda Company Profile
-
Table Takeda Peptide-based Drug Revenue, Price and Gross (2018-2023)
-
Table Ferring Company Profile
-
Table Ferring Peptide-based Drug Revenue, Price and Gross (2018-2023)
-
Table J & J Company Profile
-
Table J & J Peptide-based Drug Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly Company Profile
-
Table Eli Lilly Peptide-based Drug Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Peptide-based Drug Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Peptide-based Drug Revenue, Price and Gross (2018-2023)
-
Table Teva Company Profile
-
Table Teva Peptide-based Drug Revenue, Price and Gross (2018-2023)
-
Table Merck Company Profile
-
Table Merck Peptide-based Drug Revenue, Price and Gross (2018-2023)
-
Table AbbVie Company Profile
-
Table AbbVie Peptide-based Drug Revenue, Price and Gross (2018-2023)
-
